Xenogen Corporation

Download PDF
Email profile changes
Upgrade this profile
Add a new company

Members:
Ammend this profile
Login

Contact Details: 860 atlantic ave alameda CA 94501 United States of America Tel: 510 291 6159 Fax: 510 291 6196 Email: WWW: www.xenogen.com/

Loading...

Recent Publications by Xenogen Corporation:
Bioluminescent imaging of bacterial biofilm infections in vivo. Whole body biophotonic imaging (BPI) is a technique that has contributed...	3rd July, 2008	Xenogen Corporation, ALameda, CA, USA.	Methods Mol Biol. 2008;431:225-39.
Bioluminescence imaging to evaluate infections and host response in vivo. The continued prospect of emerging pathogens and recent events including...	20th June, 2008	Xenogen Corporation, Alameda, CA, USA.	Methods Mol Biol. 2008;415:101-18. DOI Direct Link
An extensive phenotypic characterization of the hTNFalpha transgenic mice. BACKGROUND: Tumor necrosis factor alpha (TNFalpha) is implicated in a wide...	27th February, 2008	Caliper Discovery Alliances & Services (Xenogen Biosciences), 5 Cedar	BMC Physiol. 2007 Dec 10;7:13. DOI Direct Link
Three-dimensional reconstruction of in vivo bioluminescent sources based on multispectral imaging. A new method is described for obtaining a 3-D reconstruction of a...	12th July, 2007	Caliper Life Sciences, Xenogen Corporation, 2061 Challenger Drive,	J Biomed Opt. 2007 Mar-Apr;12(2):024007. DOI Direct Link
The contribution of endogenous opioids to food reward is dependent on sex and background strain. Complex behaviors such as those associated with reward to unconditioned...	16th March, 2007	Center for the Study of Weight Regulation, Oregon Health and Science	Neuroscience. 2007 Jan 5;144(1):17-25. Epub 2006 Oct 13. DOI Direct Link
→View more Xenogen Corporation research publications.

BioNews Results for Xenogen Corporation:
Inovio Biomedical Achieves 75% Complete Response Rate in Preclinical Testing of DNA-Based Cancer Vaccine Using	SkyNewswire.com:  Sep 16 2008 8:06PM Matching: xenogen
Inovio Biomedical Achieves 75% Complete Response Rate in Preclinical Testing of DNA-Based Cancer Vaccine Using	Pharma Live:  Sep 15 2008 1:15PM Matching: xenogen
Inovio Biomedical achieves 75% complete response rate in preclinical testing of DNA-based cancer vaccine using	News-Medical.Net:  Sep 15 2008 8:56AM Matching: xenogen
Inovio Biomedical Achieves 75% Complete Response Rate in Preclinical Testing of DNA-Based Cancer Vaccine Using	Red Orbit:  Sep 14 2008 7:18PM Matching: xenogen
Inovio Biomedical Achieves 75% Complete Response Rate in Preclinical Testing of DNA-Based Cancer Vaccine Using	Genetic Engineering News:  Sep 14 2008 3:17PM Matching: xenogen
Promote your company here: BioNewsCast - Press Release Distribution	→View more Xenogen Corporation news.

Xenogen Corporation Patents:
US Patent No.	Title
7403812	Method and apparatus for determining target depth, brightness and size within a body region
6919919	Light calibration device for use in low level light imaging systems
6901279	Imaging apparatus
6894289	Fluorescence illumination assembly for an imaging apparatus
6867348	Methods and compositions for screening for angiogenesis modulating compounds
→View more Xenogen Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 885 times since April 2007, the link to the organisation's website has been followed 171 times

Recent Search Terms used to find this page: Xenogen | Xenogen | xenogen | xenogen | xenogen | xenogen | Xenogen | whole body imaging xenogen | xenogen target cancer | Xenogen | .

Search for more companies in alameda

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Xenogen Corporation

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.